Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

被引：0
|
作者：
Paiva, Bruno [1 ]
Lopez-Corral, Lucia [1 ]
Vidriales, Maria-Belen [1 ]
Sanchez Abarca, Luis Ignacio [1 ]
Hernandez, Miguel T. [2 ]
Bargay, Joan [3 ]
De La Rubia, Javier [4 ]
Giraldo, Pilar [5 ]
Teruel, Ana-Isabel [6 ]
Rosinol, Laura [7 ]
Oriol, Albert [8 ]
Hernandez, Jose [9 ]
de Arriba, Felipe [10 ]
Esteves, Graca [11 ]
Perez Simon, Jose Antonio [1 ]
Mateos, Maria-Victoria [1 ]
San Miguel, Jesus F. [12 ]
机构：
[1] Hosp Univ Salamanca, Salamanca, Spain
[2] Hosp Univ Canarias, Serv Hematol Clin, Tenerife, Spain
[3] CETLAM Cooperat Grp, Palma de Mallorca, Spain
[4] Hosp La Fe, E-46009 Valencia, Spain
[5] Hosp Miguel Servet, Zaragoza, Spain
[6] Hosp Clin Univ Valencia, Valencia, Spain
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] CETLAM Cooperat Grp, Badalona, Spain
[9] Hosp Gen Segovia, Segovia, Spain
[10] Hosp Morales Messeguer, Murcia, Spain
[11] Hosp Santa Maria, Lisbon, Portugal
[12] Hosp Clin Univ, Salamanca, Spain
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：794 / 795
页数：2
相关论文
共 50 条
  • [41] Flow Cytometry-Based Enumeration and Functional Characterization of CD8 T Regulatory Cells in Patients with Multiple Myeloma Before and After Lenalidomide Plus Dexamethasone Treatment
    Raja, Karthick Raja Muthu
    Plasil, Martin
    Rihova, Lucie
    Pelcova, Jana
    Adam, Zdenek
    Hajek, Roman
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2014, 86 (04) : 220 - 228
  • [42] Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
    Christina Hadjiaggelidou
    Evdokia Mandala
    Evangelos Terpos
    Efthalia Yiannaki
    Dimitra Markala
    Theodora Triantafyllou
    Athanasios Papatheodorou
    Vassiliki Gkastari
    Evgenia Verrou
    Asimina Papanikolaou
    Pavlina Konstantinidou
    Eirini Katodritou
    Annals of Hematology, 2019, 98 : 1457 - 1466
  • [43] Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
    Hadjiaggelidou, Christina
    Mandala, Evdokia
    Terpos, Evangelos
    Yiannaki, Efthalia
    Markala, Dimitra
    Triantafyllou, Theodora
    Papatheodorou, Athanasios
    Gkastari, Vassiliki
    Verrou, Evgenia
    Papanikolaou, Asimina
    Konstantinidou, Pavlina
    Katodritou, Eirini
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1457 - 1466
  • [44] Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis
    Paiva, Bruno
    Victoria Mateos, Maria
    Ignacio Sanchez-Abarca, Luis
    Puig, Noemi
    Vidriales, Maria-Belen
    Lopez-Corral, Lucia
    Corchete, Luis A.
    Hernandez, Miguel T.
    Bargay, Joan
    de Arriba, Felipe
    de la Rubia, Javier
    Teruel, Ana-Isabel
    Giraldo, Pilar
    Rosinol, Laura
    Prosper, Felipe
    Oriol, Albert
    Hernandez, Jose
    Esteves, Graca
    Jose Lahuerta, Juan
    Blade, Joan
    Antonio Perez-Simon, Jose
    San Miguel, Jesus F.
    BLOOD, 2016, 127 (09) : 1151 - 1162
  • [45] Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial
    Usmani, Saad Z.
    Hoering, Antje
    Ailawadhi, Sikander
    Sexton, Rachael
    Lipe, Brea
    Hita, Sandi Fredette
    Valent, Jason
    Rosenzweig, Michael
    Zonder, Jeffrey A.
    Dhodapkar, Madhav
    Callander, Natalie
    Zimmerman, Todd
    Voorhees, Peter M.
    Durie, Brian
    Rajkumar, S. Vincent
    Richardson, Paul G.
    Orlowski, Robert Z.
    LANCET HAEMATOLOGY, 2021, 8 (01): : E45 - E54
  • [46] Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
    B Paiva
    N-C Gutiérrez
    X Chen
    M-B Vídriales
    M-Á Montalbán
    L Rosiñol
    A Oriol
    J Martínez-López
    M-V Mateos
    L López-Corral
    E Díaz-Rodríguez
    J-J Pérez
    E Fernández-Redondo
    F de Arriba
    L Palomera
    E Bengoechea
    M-J Terol
    R de Paz
    A Martin
    J Hernández
    A Orfao
    J-J Lahuerta
    J Bladé
    A Pandiella
    J-F San Miguel
    Leukemia, 2012, 26 : 1862 - 1869
  • [47] Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.
    Gonsalves, Wilson I.
    Rajkumar, S. Vincent
    Timm, Michael
    Morice, William
    Dispenzieri, Angela
    Lacy, Martha
    Buadi, Francis
    Dingli, David
    Go, Ronald S.
    Leung, Nelson
    Kapoor, Prashant
    Hayman, Suzanne R.
    Lust, John Anthony
    Russell, Stephen
    Zeldenrust, Steven R.
    Kourelis, Taxiarchis
    Hwa, Yi Lisa
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
    Paiva, B.
    Gutierrez, N-C
    Chen, X.
    Vidriales, M-B
    Montalban, M-A
    Rosinol, L.
    Oriol, A.
    Martinez-Lopez, J.
    Mateos, M-V
    Lopez-Corral, L.
    Diaz-Rodriguez, E.
    Perez, J-J
    Fernandez-Redondo, E.
    de Arriba, F.
    Palomera, L.
    Bengoechea, E.
    Terol, M-J
    de Paz, R.
    Martin, A.
    Hernandez, J.
    Orfao, A.
    Lahuerta, J-J
    Blade, J.
    Pandiella, A.
    San Miguel, J-F
    LEUKEMIA, 2012, 26 (08) : 1862 - 1869
  • [49] Fixed Duration Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Maintenance Leads to High Rates of Sustained MRD Negativity in Patients with High-Risk Smoldering Multiple Myeloma: Long Term Follow up of an Investigator Initiated Phase 2 Trial
    Hill, Elizabeth
    Roswarski, Joseph L.
    Bhaskarla, Amrit
    Emanuel, Michael
    Petrosyan, Ani
    Wang, Hao-Wei
    Yuan, Constance M.
    Lindenberg, Liza
    Mena, Esther
    Turkbey, Baris
    Patel, Nisha
    Maric, Irina
    Dulau-Florea, Alina
    Calvo, Katherine
    Braylan, Raul C.
    Stetler-Stevenson, Maryalice
    Steinberg, Seth M.
    Figg, William
    Kazandjian, Dickran
    BLOOD, 2023, 142
  • [50] The clinical value of T lymphocyte subsets and NK cells in peripheral blood of patients with high-risk HPV infection and different cervical lesions
    Li, Jun
    Wang, Yi-Yu
    Yuan, Rong
    Tian, Xiao-Fei
    Yan, Tao
    Liu, Ying
    Nan, Xing
    Wang, Ping
    Fu, Yu-Lan
    Wang, Guo-Qing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 4521 - 4526
12345